Connor, Clark & Lunn Investment Management (CC&L)
APYX icon

Connor, Clark & Lunn Investment Management (CC&L)’s Apyx Medical APYX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-16,945
Closed -$85.2K – 1357
2023
Q2 		$85.2K Buy
+16,945
New +$85.9K ﹤0.01% 1251
2022
Q3 		– Sell
-15,396
Closed -$90K – 1104
2022
Q2 		$90K Buy
+15,396
New +$79K ﹤0.01% 987

Other funds holding APYX

ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s APYX Position: Q3 2023 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Apyx Medical (APYX) in Q3 2023, closing a stake of 16,945 shares — an estimated $85.2K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in APYX in Q2 2022 and held it in 2 quarters. The position peaked at $90K in Q2 2022. 62 funds tracked by Wall St. Rank hold APYX as of Q3 2023.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Apyx Medical position as of Q3 2023 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 16,945 Apyx Medical shares in Q3 2023, an estimated $85.2K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Apyx Medical in Q2 2022 and held it in 2 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Apyx Medical position peaked at $90K in Q2 2022.
  • 62 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2023.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2023, filed 13 Nov 2023.